On the recordApril 25, 2022
Congress charged the FDA, not CMS, to be the agency responsible for evaluating the safety and efficacy of biomedical products.
Source
congress.govEditor's note · Context
Senator Collins emphasizes FDA's primary role in evaluating biomedical product safety.
Share & report
More from Susan Collins
Jun 12, 2025
PEPFAR cuts make no sense to me whatsoever, given the extraordinary record of PEPFAR in saving lives.
Other voices in this conversation
